Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approachVarduhi Petrosyan, Michael T. Lewis, Lacey E. Dobrolecki et al.|iScience|2022Cited by 35
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy ResponsesJonathan T. Lei, Michael T. Lewis, Suhas Vasaikar et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 3
Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast CancerNicholas J. Neill, Charles M. Perou, Shankha Satpathy et al.|Cancer Discovery|2025Cited by 3
Data from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast CancerNicholas J. Neill, Charles M. Perou, Shankha Satpathy et al.|Unknown|2025Cited by 0
Figure S2 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast CancerNicholas J. Neill, Charles M. Perou, Shankha Satpathy et al.|Unknown|2025Cited by 0